Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality

MeSH terms

• Consumer Product Safety
• Drug Contamination / prevention & control*
• Drug Stability
• Drug Storage
• Drug-Related Side Effects and Adverse Reactions
• Particle Size
• Pharmaceutical Preparations / administration & dosage
• Pharmaceutical Preparations / standards*
• Quality Control
• Recombinant Proteins / administration & dosage
• Recombinant Proteins / adverse effects
• Recombinant Proteins / standards*